Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial - Concepedia

Concepedia

Publication | Closed Access

Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial

432

Citations

19

References

2020

Year

Richard G. Wunderink, Yuko Matsunaga, Mari Ariyasu, Philippe Clevenbergh, Roger Echols, Keith S. Kaye, Marin H. Kollef, Anju Menon, Jason M. Pogue, Andrew F. Shorr,

The Lancet Infectious Diseases

AntibioticsRespiratory InfectionSepsisExtended-infusion MeropenemNon-inferiority TrialMedicineCefiderocol Versus

References

	Year	Citations

Page 1